Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Koneczny I, Herbst R. Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture. Cells. 2019;8(7):671.
2. Özel F, Altunkan AA, Azizoğlu M. Postoperative respiratory failure in a patient with undiagnosed myastenia gravis. Turk J Anaesthesiol Reanim. 2016;44(2):108–10.
3. Braz NFT, Rocha NP, Vieira ÉLM, Barbosa IG, Gomez RS, Kakehasi AM, Teixeira AL. Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis. J Clin Neurosci. 2018;50:41–4.
4. Díaz-Maroto I, García-García J, Sánchez-Ayaso PA, Alcahut-Rodríguez C, González-Villar E, Pardal-Fernández JM, Segura T. (2020). Ocular myasthenia gravis and risk factors for developing a secondary generalization: Description of a Spanish series. Neurology (Engl Ed) 15, S0213–4853(20)30300–5.
5. Guo RJ, Gao T, Ruan Z, Zhou HY, Gao F, Xu Q, Yu LP, Wu SD, Lei T, Li HH, Sun C, Zhang M, Gao YW, Lu XD, Tang YL, Tang BL, Huo FY, Zhu Y, Li ZY, Chang T. Risk factors for generalization in patients with ocular myasthenia gravis: a multicenter retrospective cohort study. Neurol Ther. 2022;11(1):73–86.